The pitfall of detoxifying enzymes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 402, Issue 1-2, 1998, Pages 179-183

  Cantelli Forti, Giorgio ^a   Hrelia, Patrizia ^a   Paolini, Moreno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cancer chemoprevention; Cytochrome P450; Detoxifying enzyme; Glutathione S transferase; Metabolism

Indexed keywords

BUTYLATED HYDROXYANISOLE; ENZYME INDUCING AGENT; GLUTATHIONE TRANSFERASE;

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DNA BINDING; ENZYME INDUCTION; GENOTOXICITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ENZYMES; HUMANS; METABOLIC DETOXICATION, DRUG; NEOPLASMS, EXPERIMENTAL;

EID: 0032543427     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00296-0     Document Type: Conference Paper

References (25)

1. [1] M.A. Morse, G.D. Stoner, Cancer chemoprevention principles and prospects, Carcinogenesis 14 (1993) 1737-1746.
2. [2] L.W. Wattenberg, Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds, J. Natl. Cancer Inst. 58 (1977) 395-398.
3. [3] L.W. Wattenberg, Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine and benzo(a)pyrene on pulmonary and forestomach neoplasia in A/J mice, Carcinogenesis 8 (1987) 1971-1973.
4. 6-methyl-guanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3 -pyridyl)-1 -butanone in A/J mouse lung, Cancer Res. 49 (1989) 2894-2897.
5. [5] G.D. Stoner, D.T. Morrissey, Y.H. Heur, E.M. Daniel, A.J. Galati, S.W. Wagner, Inhibitory effects of phenethyl isothiocyanate on n-nitrosobenzylmethylamine carcinogenesis in the rat esophagus, Cancer Res. 51 (1991) 2063-2068.
6. [6] L.W. Wattenberg, Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles, Cancer Res. 38 (1978) 1410-1413.
7. [7] R.H. Dashwood, D.N. Arbogast, A.T. Fong, J.D. Hendricks, G.S. Bailey, Mechanisms of anti-carcinogenesis by indole-3-carbinol: detailed in vivo DNA binding dose-response studies after dietary administration with aflatoxin B1, Carcinogenesis 9 (1988) 427-443.
8. [8] T. Tanaka, Y. Mori, Y. Morishita, A. Hara, T. Ohno, T. Kojima, H. Mori, Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats, Carcinogenesis 11 (1990) 1403-1406.
9. [9] L.M. Calle, P.D. Sullivan, Screening of antioxidants and other compounds for anti-mutagenic properties towards benzo(a)pyrene-induced mutagenicity in strain TA 98 of Salmonella typhimurium, Mutation Res. 101 (1988) 99-114.
10. [10] L.A. Shelef, B. Chin, Effect of phenolic anti-oxidant on the mutagenicity of aflatoxin B1, Appl. Environ. Microbiol. 40 (1980) 1039-1043.
11. [11] J.K. Chipman, J.E. Davies, Reduction of 2-acetylaminofluorene-induced unscheduled DNA synthesis in human and rat hepatocytes by butylated hydroxytoluene, Mutation Res. 207 (1988) 193-198.
12. [12] T.W. Kensler, P.A. Egner, M.A. Trush, E. Bueding, J.D. Groopman, Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic anti-oxidants, etoxyquin and dithio-thione, Carcinogenesis 6 (1985) 759-763.
13. 7-guanyl fonnation and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione-S-transferase, Cancer Res. 46 (1986) 3924-3931.
14. [14] T.W. Kensler, P.A. Egner, P.M. Dolan, J.D. Groopman, B.D. Roebuch, Mechanism of protection against aflatoxin tumorigenicity in rats fed 5,2-pyrinazyl-4-methyl-1,2-dithiol-3-th-ione (oltpraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones, Cancer Res. 47 (1987) 4271-4277.
15. [15] M.D. Waters, A.L. Brady, H.F. Stock, H.E. Brockman, Anti-mutagenicity profiles for some model compounds, Mutation Res. 238 (1990) 57-85.
16. [16] P. Hrelia, L. Murelli, M. Paolini, G. Cantelli-Forti, In vivo protective role of anti-oxidants against genotoxicity of metronidazole and azanidazole, Drugs Exp. Clin. Res. XIII (S) (1987) 577-583.
17. [17] F.P. Guengerich, Enzymatic activation of chemicals to toxic metabolites, CRC Crit. Rev. Toxicol. 14 (1985) 259-307.
18. [18] A.W. Wood, W. Levin, A.Y.H. Lu et al., Metabolism of benzo(a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes, J. Biol. Chem. 25 (1976) 4882-4890.
19. [19] C.B. Kasper, D. Henion, Glucuronidation, in: W.B. Jacoby (Ed.), Enzymatic Basis of Detoxification, Academic Press, New York, 1980, pp. 3-12.
20. [20] C.R. Wolf, P.N. Berry, J.A. Nash, T. Green, E.A. Lock, Role of microsomal and cytosolic glutathione-S-transferase in conjugation of hexachlor-1,3-butadiene and its possible relevance to toxicity, J. Pharmacol. Exp. Ther. 228 (1984) 202-208.
21. [21] P.E. Hanna, R.B. Banks, Suicide inactivation of hamster hepatic arylhydroxaminoacide N,O-acyltransferase: a selective probe of N-acetyltransferase multiplicity, Mol. Pharmacol. 21 (1992) 159-168.
22. [22] M. Paolini, L. Pozzetti, R. Mesirca, A. Sapone, P. Silingardi, S. Grilli, C. Dalla Croce, G. Bronzetti, G. Cantelli-Forti, Role of phase-II enzymes in the bioactivation of 1,4-dichlorobenzene and 1,4-dibromobenzene, ATLA-Altern. Lab. Anim. 24 (1996) 803-806.
23. [23] Y.N. Cha, F. Marts, E. Buending, Enhancement of liver microsoms epoxide hydrolase activity in rodents by treatment with 3(3)-tert-butyl-4-hydroxyanisole, Cancer Res. 38 (1975) 4496-4498.
24. [24] M. Paolini, R. Mesirca, L. Pozzetti, P. Silingardi, S. Grilli, G. Cantelli-Forti, Strategies for advancement of short-term mutagenicity tests: on the optimal ionic strength for the liver microsomal assay, Carcinogenesis 13 (1992) 1403-1405.
25. [25] R. Thier, M. Müller, J.B. Taylor, S.E. Penible, B. Ketterer, F.P. Guengerich, Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione-S-transferase, Chem. Res. Toxicol. 8 (1995) 465-472.